Results 271 to 280 of about 61,522 (308)

Opportunities and challenges in phenotypic drug discovery: an industry perspective

Nature Reviews Drug Discovery, 2017
Fabien Vincent, Jonathan A Lee, Marco Prunotto   +2 more
exaly  

Angiogenesis Inhibitors: Current Strategies and Future Prospects

Ca-A Cancer Journal for Clinicians, 2010
Kristina M Cook, William D Figg
exaly  

[Drug incompatibility].

Fel'dsher i akusherka, 1981
openaire   +1 more source

[Drug incompatibility].

Il Farmaco; edizione pratica, 1973
openaire   +1 more source

Subcellular targeting strategies for drug design and delivery

Nature Reviews Drug Discovery, 2010
Lawrence Rajendran, Hans-Joachim Knölker   +1 more
exaly  

Predicting Incompatibilities Of New Drugs

Journal of the American Pharmaceutical Association (Practical Pharmacy ed.), 1952
openaire   +1 more source

Food and Drug Administration, Partner in Drug Development

Ca-A Cancer Journal for Clinicians, 2006
exaly  

Trends in GPCR drug discovery: new agents, targets and indications

Nature Reviews Drug Discovery, 2017
Alexander S Hauser, Misty M Attwood, Mathias Rask-Andersen   +2 more
exaly  

Therapeutic Incompatibilities of Legend Drugs with OTE Drugs

Journal of the American Pharmaceutical Association (1961), 1968
Lawrence H. Block, Peter P. Lamy
openaire   +1 more source

ANTISENSE DRUG ENHANCES RESPONSE IN CHEMORESISTANT MELANOMAS

Ca-A Cancer Journal for Clinicians, 2001
exaly